Author

Shuhan Kong

Max Delbrück CenterORCID 0009-0008-0164-3346Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Dimitra PapaioannouiD· 2 shared Jan HalbritteriD· 2 shared Kai‐Uwe EckardtiD· 2 shared Michael M. KaminskiiD· 2 shared Ria Anne-Rose SchönaueriD· 2 shared Sarah WendlingeriD· 2 shared Verena KlämbtiD· 2 shared Amr Al‐ShebeliD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetics

Dimitra PapaioannouORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GeneticsbioRxivPreprintOct 16, 2026

Base Editing as a Therapeutic Strategy for Autosomal Dominant Tubulointerstitial Kidney Disease caused by Pathogenic UMOD Variants

Nora Diederich, Sarah Wendlinger, Shuhan Kong…·Michael M. Kaminski

This paper evaluates base editing strategies for treating ADTKD-UMOD by correcting pathogenic UMOD variants and inactivating mutant alleles, showing efficient correction and expression modulation in cell models.

DOI 10.64898/2026.10.15.758759

humanexperimental assay

𝕏 PostBluesky

GeneticsMolecular TherapyPeer-reviewedAug 21, 2025

In vivo base editing reduces liver cysts in autosomal dominant polycystic kidney disease

Antonia Ibel, Rishi Bhardwaj, Duygu Elif Yılmaz…·Michael M. Kaminski

This study shows that CRISPR base editing can correct pathogenic PKD1 variants in mice, reducing liver cysts and increasing polycystin-1 expression.

9 citationstop 3%

mouseexperimental assay

𝕏 PostBluesky